Priscilla Hoang, MD
Interventional Cardiology · Kirkland, WANPI 1326295825
Payments from drug & device makers
Across 35 payments — averaging $97.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$2K
- Abbott$1K
- Terumo Medical Corporation$129
- Medtronic$105
- Shockwave Medical, Inc$33
- Kestra Medical Technology Services, Inc.$31
- plus $124 from 6 others
What the payments were for
- Speaking & faculty fees$1,70050%
- Travel & lodging$94428%
- Food & beverage$75322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1 | $1,700 |
| Abbott | 14 | $1,275 |
| Terumo Medical Corporation | 5 | $129 |
| Medtronic(2 entities) | 5 | $105 |
| Shockwave Medical, Inc | 2 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Edwards Lifesciences | 2 | $26 |
| Abiomed | 1 | $23 |
| Microvention, Inc. | 1 | $21 |
| Biotronik Inc. | 1 | $20 |
| Inari Medical, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,396 in reported general payments places this provider in the 45th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 210 | $235,692 |
| XareltoRivaroxaban | 45 | $63,529 |
| EntrestoSacubitril/Valsartan | 14 | $20,554 |
| Metoprolol Succinate | 413 | $5,921 |
| Atorvastatin Calcium | 305 | $4,728 |
| Candesartan Cilexetil | 36 | $4,616 |
| Rosuvastatin Calcium | 142 | $2,049 |
| Valsartan | 51 | $1,921 |
| Amiodarone Hcl | 17 | $1,756 |
| Lisinopril | 172 | $1,687 |
| Carvedilol | 156 | $1,585 |
| Losartan Potassium | 158 | $1,463 |
| Amlodipine Besylate | 171 | $1,226 |
| ClopidogrelClopidogrel Bisulfate | 83 | $1,026 |
| Verapamil ErVerapamil Hcl | 16 | $1,012 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Kirkland
- Patrick MarcusKirkland$27K
- Sameer GafoorSeattle$2M
- James McCabeSeattle$1.7M
- William LombardiSeattle$1.2M
- Sidakpal PanaichSeattle$1.2M
- Kathleen KearneySeattle$802K
- Ming ZhangSeattle$693K
- Robert RileyBellevue$652K
- Mahesh MulumudiEverett$569K
- Danny DvirSeattle$380K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.